Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
申请人:Chappell Mark Donald
公开号:US20080319074A1
公开(公告)日:2008-12-25
The present invention discloses novel compounds of Formula (I), or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.
A compound of ##STR1## (wherein n is an integer from 2 to 15; R' is ##STR2## m is total number of carbon atoms in R' and is an integer from 5 to 12, and * mark shows asymmetric carbon atom) which is useful for an electric indicative element of liquid crystal is provided.